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Abstract. Rubella is a generally mild illness and its serious complications are rare. Although a   
major section of pregnant women are immuned, cases of rubella infection occur in Nigeria among 
pregnant women. This study was carried out to assess the prevalence of rubella virus IgM among 
obstetric population aged 15 – 47 with an average mean of 28.5 years attending Antenatal Clinic 
Muhammad Abdullahi Wase Specialist Hospital Kano. Of the total 288 patients screened, 50 
(17.4%) were reactive to rubella IgM. Out of 50 infected patients 20 (6.95%) were from 20 – 24 
years age bracket representing the most  susceptible age group while the infection rate was lowest 
(0.35%) in 45 – 49 age group, even though when statistically analyzed rubella susceptibility is not 
age dependent (P = 0.894). Moreover, obstetric history and obstetric losses among various age 
groups with respect to rubella sero – prevalence shows that of the 50 reactive patients, 35 had a 
previous abnormal obstetric history. Premature delivery was observed to be almost uniform 
across all the ages with a prevalence rate of (13.0%), still birth was having the same prevalence 
with that of premature delivery but with highest frequency in 20-24 years age group. However 
congenital anomalies was found to have least prevalence rate of (6.5%), neonatal death has 
prevalence rate of 10.5% with declining frequency towards the ages of 35-49 years (P=0.02). It was 
found that rubella infection still occurs and rubella susceptibility has no relationship with age 
group. 
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Introduction 
Rubella, commonly known as German measles, is a disease caused by the rubella 
virus. The name “rubella” is derived from the Latin, meaning little red. Rubella is 
generally a mild illness and serious complications are rare. However, primary 
maternal rubella virus infection during the first trimester of pregnancy carries a 
high risk for the development of congenital rubella syndrome (CRS) with 
characteristic malformations of the heart, eye and ear or even death of the fetus. 
Although rubella vaccination has reduced the incidence of rubella virus 
substantially; the World Health Organization (WHO) estimates that worldwide 
more than 110,000 cases of CRS are from developing countries [16]. 
In Nigeria, previous studies among pregnant women have detected rubella IgG 
antibodies to 68.5% in Ibadan, 54.1% in Maiduguri and 76% in Lagos [1] [3] [10] . 
Also in the seventies in a multicenter study (North East and West Nigeria), [8] 
showed that an average of 68% of the Nigerian population possessed rubella 
antibody [6]. Therefore on the average, approximately 66.2% of pregnant women 
in Nigeria are already immune to rubella infection probably due to subclinical or 
clinical exposure to rubella virus as there is no policy for immunization against 
rubella infection and there is a 33.8% susceptible population [6]. Although a 
major section of pregnant women in Nigeria are immuned, cases of CRS are still 
been seen in hospitals. For example, in 2006, a case of confirmed CRS was 
deported in Port-Harcourt in a three month old male with heart failure [11]. This 
means that pregnant women continue to harbor the virus despite the availability 
of an effective vaccine. Rubella is not reportable disease in Nigeria and data of its 
burden are extremely rare [16].  
 
MATERIALS AND METHODS 
Study Population 
The population studied was a homogenous of different age groups, ethnicities, 
educational and socio-economical status. 
Study Design 
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General descriptive study was used to design out a cross-sectional (prevalence) 
survey which will be carried out according to the ethical standard for human 
experimentation. An ethical clearance was obtained from Hospitals Management 
Board Kano. A written informed consent form was also administered. 
Sample size 
A total of 288 pregnant women who completed the patient’s consent form    were 
recruited for this study. 
Sample Collection/Storage 
The upper arm of the subject was tied with a tourniquet; the ante cubital region 
was disinfected with 70% alcohol. 5mls of blood was drawn by venepuncture using 
a sterile syringe through the antecubital vein. The tourniquet was removed and 
the puncture blocked with cotton wool and moderate pressure was applied to stop 
bleeding, the blood was transferred into sterile centrifuge tube and allowed to clot. 
The clotted blood samples was spun at 300rpm for 10mins, the serum was 
separated and transferred 5ml universal container and stored at -200C until use 
[4] . 
Screening for Rubella Antibody (Rubella IgM) 
Rubella virus antibody was analyzed using enzyme-linked immunosorbent assay 
(ELISA) which is the most sensitive and reliable procedure for detection of 
antibodies to Rubella [12]. 
 
RESULTS 
Out of the 288 pregnant women screened, 50 patients were reactive to rubella 
IgM antibody showing a prevalence rate of (17.4%). Similarly, out of a total of 288 
patients enrolled for the study 2 patients were sero-reactive to HIV. It was 
observed that the advancing age is associated with progressively decreasing odd 
of rubella susceptibility. The age of the women studied ranged from 15 – 47 years 
with a mean of 28.25 years. There was a steady in the age groups of the obstetric 
population studied with a peak in the 20 – 24 years and a decline toward 30 – 47 
years age group. 
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Table 1: Rubella Susceptibility Among Various Age Groups  
Age Group (years No. Screened Rubella IgM (%) Prevalence 
15 – 19 21 2 (0.70) 
20 – 24 115 20 (6.95) 
25 – 29 81 15 (5.22) 
30 – 34 45 7 (2.44) 
35 – 39 22 5 (1.74) 
40 – 44 3 1 (0.35) 
45 – 49 1 0 (0.00) 
Total 288 50 (17.4) 
 (P = 0.894) 
Moreover, obstetric history and obstetric loses among various age group with 
respect to rubella IgM sero – prevalence was observed. Of the 50 sero – reactive 
rubella IgM studied, 35 had a previous abnormal obstetric history. Abortions 
constituted a highest percentage of (62.9%) with highest frequency among 30 – 34 
years age group and least in 15 – 19 years age group.  
 
Table 2: Seroprevalence of Rubella IgM Antibodies According to Various Obstetric 
Losses Among Various Age Groups. 
  Obstetric history                                 Various Age Group (Years) 
 15 –19  20-24 25 –29 30 –34 35 –39 39 40-44  45-49  Percentage 
Abortions 1 3 5 8 4 1        -  22 (62.9) 
Premature delivery - 1 - 1 1 1        -  4 (11.4) 
Still birth   2 1 - 1 -         -  4 (11.4) 
Congenital anomalies - - - 1 - 1         -  2 (5.7) 
Neonatal death - - - - 1 1        1  3 (8.6) 
Total 1 6 6 10 7 4         1  35 (100) 
(P = 0.02) 
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DISCUSSIONS 
Rubella antibodies appear in the serum of patients as the rash fades 1 – 3 weeks. 
Much of the initial antibody consists of IgM antibodies, which generally do not 
persist beyond 6 weeks after the illness. IgM rubella antibodies found in single 
serum obtained 2 weeks after the rash give evidence of recent rubella infection 
[2] . 
When a women is infected with the rubella virus early in pregnancy, she has a 90% 
chance of passing the virus on to her fetus and this can cause the death of the 
fetus or it may cause CRS [6]. 
Rubella viruses is known to cause infection in vitro and are often responsible for 
abortion, still births premature delivery and congenital malformation. There is 
considerable variable in the prevalence of the agent among the women of child in 
the prevalence of the agent among the of child bearing age in different 
geographical areas [15]. 
In this present study a prevalence rate of 17.4% was reported i.e the subject 
studied had a detectable IgM level which is a marker of recent infection. 
Detection of IgM is well established as a means of diagnosing recent rubella/CRS 
and is recommended by the WHO as the primary test for the laboratory 
confirmation of rubella. In present study antibodies to rubella were found in 17.4% 
women which is accordance with the study of [15] with 17.5% prevalence rate and 
that of[13] with 17.7%  prevalence rate. However, the figure 17.4% is in line with 
the WHO Worldwide prevalence rate of rubella susceptibility i.e 7.5 – 17.4% [5]. 
The result obtained 17.4% is however higher than 4.2% found in pregnant women 
in Makurdi, Beneu State [6] and 10.0% also among pregnant women attending 
antenatal clinic Benin Teaching Hospitals [9] . Moreover, [17] [7], reported 6.5% 
and 10.38% respectively. Whereas [14] reported rubella IgM positivity as 26.8%. 
The difference in the prevalence rate may be due to the season in which the 
samples were collected, geographical location, cultural behavior, ethnicity, sexual 
behavior and socio economic status. The wide variation may also be due to the 
fact that the study area i.e. Muhammad Abdullahi Wase Specialist Hospital 
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antenatal clinics attend to different group of people from various destinations of 
multiple ethnicities. All the women who participated in this study were between 
the ages of 15 – 47 years. Although the highest prevalence was observed in 20 – 
24 years age group, but when analyzed statistically the (P > 0.05) which signifies 
that there is no significant difference i.e rubella has no relationship with age 
groups. This agrees with the finding of serologic survey rubella IgM in pregnant 
in Makurdi which shows that (P > 0.05) and considered statistically not 
significant [6]. 
 
CONCLUSION 
This study confirms a high sero prevalence of Rubella Virus infection among 
obstetric population in Kano metropolis antenatal centre. It is therefore 
recommended that pregnant women should be routinely screened for Rubella 
Virus IgM as part of their antenatal care and the vaccine should be administered 
prior to their delivery avoiding the risk of vertical transmission from mother to 
child. 
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